Oxford-based immuno-oncology play Adaptimmune has been obliged by the FDA to alter the trial design of a Phase I/II study in patients with MRCLS. A partial clinical hold was lifted now.
https://european-biotechnology.com/wp-content/uploads/2024/04/ADAPTIMMUNE-_JamesNoble.jpg6751200Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2016-11-11 12:24:442016-11-11 12:24:44Adaptimmune downgrades trial design after FDA clinical hold
Belgian and German researchers have presented a new imaging tool that can track immune cells invading the brain in the initial stages of multiple sclerosis (MS).
https://european-biotechnology.com/wp-content/uploads/2024/04/MS.jpg1138840Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2016-11-10 13:12:182016-11-10 13:12:18Multiple sclerosis diagnosis in early stage
https://european-biotechnology.com/wp-content/uploads/2024/04/Opis_Whitepaper_Compass.png531945Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2016-11-10 10:17:502016-11-10 10:17:50COMPASS Innovative web-platform developed by OPIS to manage Compassionate Use Programmes
Roche ramps up immunotherapy R&D
Latest NewsSwiss cancer meds world market leader Roche intensifies its focus on translational research to broaden the scope of cancer immunotherapies.
Roche ramps up immunotherapy R&D
Latest NewsSwiss cancer meds world market leader Roche intensifies its focus on translational research to broaden the scope of cancer immunotherapies.
Roche ramps up immunotherapy R&D
Latest NewsSwiss cancer meds world market leader Roche intensifies its focus on translational research to broaden the scope of cancer immunotherapies.
Roche ramps up immunotherapy R&D
Latest NewsSwiss cancer meds world market leader Roche intensifies its focus on translational research to broaden the scope of cancer immunotherapies.
Roche ramps up immunotherapy R&D
Latest NewsSwiss cancer meds world market leader Roche intensifies its focus on translational research to broaden the scope of cancer immunotherapies.
Roche ramps up immunotherapy R&D
Latest NewsSwiss cancer meds world market leader Roche intensifies its focus on translational research to broaden the scope of cancer immunotherapies.
Adaptimmune downgrades trial design after FDA clinical hold
Latest NewsOxford-based immuno-oncology play Adaptimmune has been obliged by the FDA to alter the trial design of a Phase I/II study in patients with MRCLS. A partial clinical hold was lifted now.
Multiple sclerosis diagnosis in early stage
Latest NewsBelgian and German researchers have presented a new imaging tool that can track immune cells invading the brain in the initial stages of multiple sclerosis (MS).
COMPASS Innovative web-platform developed by OPIS to manage Compassionate Use Programmes
Sponsored PublicationsCompassionate use is a treatment option that allows the use of an unauthorised medicine.
Cell Proliferation Kits III
ProductsPromoKines new Cell Proliferation Assays are fast and sensitive and EdU-based.